Product Information
APTENSIO XR 15 MG CAPSULE is a brand product labeled by Rhodes Pharmaceuticals L.P., priced at $7.9647 per EA under NDC 42858040245. Its NADAC has been published 166 times since Feb 19, 2020.
FDA first approved this application on Apr 17, 2015. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
15 mg/1
Manufacturer
Rhodes Pharmaceuticals L.P.NDC
42858040245
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
11/19/2025
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA205831FDA Approved
4/17/2015
TE Code
AB3
On Market Since
4/17/2015
Pharmacological Classes
Price Statistics
The NADAC for APTENSIO XR 15 MG CAPSULE has been published 166 times since Feb 19, 2020, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.9647 per EA |
|---|---|
| All-time high | $8.0184 (Dec 11, 2024) |
| All-time low | $7.9500 (Feb 19, 2025) |
| 52-week high | $7.9647 |
| 52-week low | $7.9647 |
| Median price | $7.9893 |
| Average price | $7.9847 |
| Largest weekly change | -0.5% (Feb 19, 2025) |
| Weeks tracked | 166 |
| Tracking since | Feb 19, 2020 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 67% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of APTENSIO XR 15 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for APTENSIO XR 15 MG CAPSULE, manufactured by Rhodes Pharmaceuticals L.P., is $7.9647 per EA (NDC 42858040245), effective Aug 19, 2026.
How has the price of APTENSIO XR 15 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for APTENSIO XR 15 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 166 weekly CMS publications since Feb 19, 2020.
What are the highest and lowest recorded NADAC prices for APTENSIO XR 15 MG CAPSULE?
Since Feb 19, 2020, the NADAC for APTENSIO XR 15 MG CAPSULE has ranged from a low of $7.9500 (Feb 19, 2025) to a high of $8.0184 (Dec 11, 2024), with a median of $7.9893 per EA.
Are there cheaper alternatives to APTENSIO XR 15 MG CAPSULE?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METHYLPHENIDATE ER 15 MG CAP, is $2.6482 per EA — about 67% below APTENSIO XR 15 MG CAPSULE.
Who manufactures APTENSIO XR 15 MG CAPSULE?
APTENSIO XR 15 MG CAPSULE (NDC 42858040245) is labeled by Rhodes Pharmaceuticals L.P., and CMS classifies it as a brand product.